Cardiovascular Research

A wild vetchling's ominous tendrils gone to the loins
pp. 551-553(3)
Author: Weber K.T.

Tumor necrosis factor in CHF: a double facet cytokine
pp. 554-559(6)
Author: Ferrari R.

Dietary arginine and the prevention of cardiovascular diseases
pp. 560-563(4)
Author: de Lorgeril M.

Weight watching in cardiology: low molecular weight heparin for acute coronary syndromes
pp. 564-566(3)
Authors: Levi M.; Peters R.J.G.; R. Buller H.

Experimental evidence for proarrhythmic mechanisms of antiarrhythmic drugs
pp. 567-577(11)
Author: Nattel S.

Peptidic regulation of heart rate and interactions with the autonomic nervous system
pp. 578-585(8)
Authors: Beaulieu P.; Lambert C.

AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept
pp. 586-600(15)
Authors: Bierhaus A.; Hofmann M.A.; Ziegler R.; Nawroth P.P.

An estimate of fetal autonomic state by spectral analysis of human umbilical artery flow velocity waveforms
pp. 601-605(5)
Authors: Ursem N.T.C.; Kempski M.H.; de Ridder M.A.J.; Clark E.B.; Wladimiroff J.W.

Expression of calcium regulatory proteins in short-term hibernation and stunning in the in situ porcine heart
pp. 606-617(12)
Authors: Luss H.; Boknk P.; Heusch G.; Muller F.U.; Neumann J.; Schmitz W.; Schulz R.

Long acting calcium antagonist amlodipine prevents left ventricular remodeling after myocardial infarction in rats
pp. 618-626(9)
Authors: Shimada T.; Yoshiyama M.; Takeuchi K.; Omura T.; Takemoto Y.; Kim S.; Iwao H.; Yoshikawa J.

Effects of the novel antiarrhythmic agent azimilide on experimental atrial fibrillation and atrial electrophysiologic properties
pp. 627-635(9)
Authors: Nattel S.; Liu L.; St-Georges D.

Flow-function relations during graded coronary occlusions in the dog: effects of transmural location and segment orientation
pp. 636-645(10)
Authors: McCulloch A.D.; Sung D.; Wilson J.M.; Pavelec R.S.; Omens J.H.

Efficacy of a -adrenergic receptor antagonist, propranolol, in preventing ischaemic ventricular fibrillation: dependence on heart rate and ischaemia duration
pp. 646-655(10)
Authors: Aupetit J.F.; Frassati D.; Bui-Xuan B.; Freysz M.; Faucon G.; Timour Q.

The low molecular weight heparin, enoxaparin, limits infarct size at reperfusion in the dog
pp. 656-666(11)
Authors: Libersan D.; Khalil A.; Dagenais P.; Quan E.; Delorme F.; Uzan A.; Latour J.-G.

Elevation of an endogenous inhibitor of nitric oxide synthesis in experimental congestive heart failure
pp. 667-675(9)
Authors: Feng Q.; Lu X.; Fortin A.J.; Pettersson A.; Hedner T.; Kline R.L.; Arnold J.M.O.

Guanylyl cyclase inhibition reduces contractility and decreases cGMP and cAMP in isolated rat hearts
pp. 676-683(8)
Authors: Klabunde R.E.; Tse J.; Weiss H.R.

Efficacy of myocardial initial reperfusion with 2,3 butanedione monoxime after cardioplegic arrest is time-dependent
pp. 684-690(7)
Authors: Habazettl H.; Voigtlander J.; Leiderer R.; Messmer K.

Oxidant stress with hydrogen peroxide attenuates calcium paradox injury: role of protein kinase C and ATP-sensitive potassium channel
pp. 691-699(9)
Authors: Miyawaki H.; Wang Y.; Ashraf M.

Effect of protein kinase C inhibitors on cardioprotection by ischemic preconditioning depends on the number of preconditioning episodes
pp. 700-709(10)
Authors: Miura T.; Miura T.; Kawamura S.; Goto M.; Sakamoto J.; Tsuchida A.; Matsuzaki M.; Shimamoto K.

Stimulation of Ca-induced Ca release only transiently increases the systolic Ca transient: measurements of Ca fluxes and sarcoplasmic reticulum Ca
pp. 710-717(8)
Authors: Trafford A.W.; Daz M.E.; Eisner D.A.

Stimulation of P2Y receptors activates c-fos gene expression and inhibits DNA synthesis in cultured cardiac fibroblasts
pp. 718-728(11)
Authors: Zheng J.-S.; O'Neill L.; Long X.; Webb T.E.; Barnard E.A.; Lakatta E.G.; Boluyt M.O.

High-density lipoprotein particles are large in patients with variant angina
pp. 729-737(9)
Authors: Miwa K.; Yoshida N.; Nakagawa K.; Inoue H.

Impairment of endothelium-dependent vasorelaxation in experimental atherosclerosis is dependent on gender
pp. 738-747(10)
Authors: Kojda G.; Husgen B.; Hacker A.; Perings D.; Schnaith E.M.; Kottenberg E.; Noack E.

Interaction between isoniazid and diverse vasodilators: role of decreased cerebral GABA
pp. 748-755(8)
Authors: de los Angeles Sanchez-Salvatori M.; Ros C.; Vidrio H.

Chronic dietary supplementation with l-arginine inhibits platelet aggregation and thromboxane A₂ synthesis in hypercholesterolaemic rabbits in vivo
pp. 756-764(9)
Authors: Bode-Boger S.M.; Boger R.H.; Kienke S.; Bohme M.; Phivthong-ngam L.; Tsikas D.; Frolich J.C.

The ET_A receptor antagonist, BMS-182874, reduces acute hypoxic pulmonary hypertension in pigs in vivo
pp. 765-771(7)
Authors: Holm P.; Liska J.; Franco-Cereceda A.

Vasodilator dysfunction in aged spontaneously hypertensive rats: changes in NO synthase III and soluble guanylyl cyclase expression, and in superoxide anion production
pp. 772-779(8)
Authors: Bauersachs J.; Bouloumie A.; Mulsch A.; Wiemer G.; Fleming I.; Busse R.

K⁺-induced dilation of a small renal artery: no role for inward rectifier K⁺ channels
pp. 780-790(11)
Authors: Prior H.M.; Webster N.; Quinn K.; Beech D.J.; Yates M.S.

Enhancement of the vasorelaxant potency of nicorandil by metabolic inhibition and adenosine in the pig coronary artery
pp. 791-798(8)
Authors: Davie C.S.; Standen N.B.

Mapping of vascular dendritic cells in atherosclerotic arteries suggests their involvement in local immune-inflammatory reactions - II. Immunocytochemical analysis of the cellular composition of atherosclerotic lesions
pp. 799-810(12)
Authors: Bobryshev Y.V.; Lord R.S.A.

Comparative reactivity and mechanical properties of human isolated internal mammary and radial arteries
pp. 811-819(9)
Authors: Chamiot-Clerc P.; Copie X.; Renaud J.-F.; Safar M.; Girerd X.

Monocyte-vascular smooth muscle cell interaction enhances nitric oxide production
pp. 820-825(6)
Authors: Ikeda U.; Maeda Y.; Funayama H.; Hojo Y.; Ikeda M.; Minota S.; Kano S.; Shimada K.

Soluble E-selectin and soluble intercellar adhesion molecule-1 in coronary artery disease
pp. 826-827(2)
Author: Blann A.D.

Soluble E-selectin and soluble intercellular adhesion molecule-1 in coronary artery disease
pp. 828-828(1)
Authors: Miwa K.; Inoue H.

?Comments on circulating transforming growth factor 1 and coronary artery disease?
pp. 829-829(1)
Authors: Fredericks S.; Syrris P.; Kaski J.C.; Jeffery S.; Holt D.W.; Carter N.D.

Circulating transforming growth factor 1 and coronary artery disease
pp. 830-830(1)
Authors: Xing L.W.; Wilcken D.E.L.

Growth hormone in cardiovascular medicine
pp. 831-832(2)
Author: Dreifuss P.

Growth hormone in cardiovascular medicine
pp. 833-833(1)
Author: Sacca L.